Skip to news
JQJO
Latest

GSK Invests $30 Billion in US Pharma | JQJO

GSK Invests $30 Billion in US Pharma

GSK Invests $30 Billion in US Pharma

Tap title to read story

0:00 / 0:40

GlaxoSmithKline (GSK) announced a $30 billion investment in US research, development, and manufacturing over the next five years. This includes $1.2 billion for advanced manufacturing, AI, and digital technologies, creating next-generation facilities. The announcement coincides with President Trump's UK state visit and follows similar large investments from other pharmaceutical companies, possibly influenced by the Trump administration's push for increased US manufacturing and lower drug prices. GSK's investment will involve a new Pennsylvania biologics factory and upgrades to existing sites.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Chiefs Add Josh Downs, Seek More

Tap title to read story

0:00 / 0:00

Oregon Ducks Lose Hill to Injury

Tap title to read story

0:00 / 0:36

Clemson QBs Beat Duke 20-10

Tap title to read story

0:00 / 0:42

Kings Mountain Wins 41‑18 Over

Tap title to read story

0:00 / 0:44

Maryville Defeats Smyrna 38‑14

Tap title to read story

0:00 / 0:42

JQJO

Find your next story

Search JQJO’s current coverage.